Market Overview

3 Charts That Tell A Deeper Story Of Wells Fargo's Q1

Share:

Wells Fargo & Co (NYSE: WFC) just reported, and I wanted to share three charts quickly. An excellent way to understand the health of the bank's balance sheet is through their net charge-offs as a percent of total loans. While this isn't a forward indicator, the directional trend can help inform us of potential future economic conditions.

Net charge-offs overall for Wells are low, trending lower, and muted. Currently, they just reported a net charge-off rate of .32%, up quarter on quarter, but down year on year.

Their credit card loan business is less rosy. The trend continues to move higher, and their earnings report indicated a 3.69% rate. This level is well above 2 years ago, and .03% above the prior quarter.

Lastly, their auto loan business. Charge-offs within autos have moved up considerably. The most recent reading was 1.64%, twice the rate seen in 2015. The trend in autos is higher, and the recent reading was well above the 2-year trend.

Autos and credit cards only make up roughly 9% of Wells overall loan book, this is why Wells isn't seeing the broader risk to their loan book. Wells focus remains in commercial and non-commercial real estate segments, which is rather healthy at the moment. However, these internal numbers are telling us that the health of the consumer is starting to deteriorate. Wells Fargo would agree, as their auto loan book has gone from $60B in March 2017, to $49B today. On to the conference call…

Sean D. Emory, Avory & Co. Founder & Chief Investment Officer

AVORY & CO. IS A REGISTERED INVESTMENT ADVISER. INFORMATION PRESENTED IS FOR EDUCATIONAL PURPOSES ONLY. PLEASE SEE FULL DISCLAIMER HERE


WELLS FARGO 3 CHARTS was originally published in Avory & Co on Medium, where people are continuing the conversation by highlighting and responding to this story.

Posted-In: contributorGeneral

 

Related Articles (WFC)

View Comments and Join the Discussion!

Mid-Day Market Update: SemiLEDs Falls Following Q2 Results; Pulse Biosciences Shares Surge

The Week Ahead In Biotech: PDUFA Dates, IPOs And More